Related Experiment Video
Updated: Nov 10, 2025
Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
Published on: September 5, 2018
Using 3D in vitro cell culture models in anti-cancer drug discovery
1Nemours Biomedical Research, Alfred I. duPont Hospital for Children, Wilmington, DE.
Introduction:
The high failure rate in drug discovery remains a costly and time-consuming challenge. Improving the odds of success in the early steps of drug development requires disease models with high biological relevance for biomarker discovery and drug development. The adoption of three-dimensional (3D) cell culture systems over traditional monolayers in cell-based assays is considered a promising step toward improving the success rate in drug discovery.
Areas Covered:
In this article, the author focuses on new technologies for 3D cell culture and their applications in cancer drug discovery. Besides the most common 3D cell-culture systems for tumor cells, the article emphasizes the need for 3D cell culture technologies that can mimic the complex tumor microenvironment and cancer stem cell niche.
Expert Opinion:
There has been a rapid increase in 3D cell culture technologies in recent years in an effort to more closely mimic in vivo physiology. Each 3D cell culture system has its own strengths and weaknesses with regard to in vivo tumor growth and the tumor microenvironment. This requires careful consideration of which 3D cell culture system is chosen for drug discovery and should be based on factors like drug target and tumor origin.
Insights
Three-dimensional (3D) cell culture models offer improved biological relevance for cancer drug discovery. Selecting the right 3D system is crucial for enhancing biomarker discovery and increasing the success rate of new therapeutics.
Area of Science:
- Oncology
- Biotechnology
- Drug Discovery
Background:
- High failure rates in drug discovery necessitate more biologically relevant disease models.
- Traditional monolayer cell cultures lack the complexity of in vivo systems, impacting drug development success.
- Three-dimensional (3D) cell culture is emerging as a promising approach to enhance preclinical models.
Purpose of the Study:
- To review novel 3D cell culture technologies for cancer drug discovery.
- To highlight the importance of mimicking the tumor microenvironment and cancer stem cell niche in 3D models.
- To guide the selection of appropriate 3D cell culture systems based on specific research needs.
Main Methods:
- Review of recent advancements in 3D cell culture technologies.
- Analysis of the application of these technologies in cancer research.
- Discussion of the strengths and limitations of various 3D systems for mimicking in vivo conditions.
Main Results:
- 3D cell culture systems increasingly replicate in vivo tumor physiology.
- Different 3D systems offer varying degrees of accuracy in modeling tumor growth and microenvironment.
- No single 3D system is universally superior; selection depends on the specific application.
Conclusions:
- 3D cell culture technologies are vital for improving the biological relevance of cancer models.
- Careful consideration of 3D system characteristics is essential for successful biomarker discovery and drug development.
- Future research should focus on 3D models that effectively recapitulate the complex tumor microenvironment.
